Matinas BioPharma Financial Overview
Matinas BioPharma's market cap is currently $6.46M. The company's EPS TTM is $-1.031; its P/E ratio is -0.33; Matinas BioPharma is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
